n-desmethylclobazam has been researched along with Allodynia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acuña, MA; Benke, D; Besson, M; Daali, Y; Desmeules, J; Matthey, A; Ralvenius, WT; Rudolph, U; Zeilhofer, HU | 1 |
1 other study(ies) available for n-desmethylclobazam and Allodynia
Article | Year |
---|---|
The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia.
Topics: Analgesics, Non-Narcotic; Animals; Benzodiazepines; Clobazam; Dose-Response Relationship, Drug; Female; HEK293 Cells; Humans; Hyperalgesia; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Protein Binding; Receptors, GABA-A | 2016 |